Has Shine Lawyers left the ASX in the dark over its Johnson & Johnson pelvic mesh fee-fest?

Is Shine Justice being straight with the ASX over its profits from the $300m pelvic mesh class action against Johnson & Johnson? Michael West investigates an accounting and disclosure mystery.